AVERITAS PHARMA
DEAD

Serial Number

97381068

Owner

Averitas Pharma, Inc.

Attorney

Paul C. Llewellyn

Filing Date

Apr 26, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AVERITAS PHARMA Trademark

Serial Number: 97381068

AVERITAS PHARMA is a trademark filed by Averitas Pharma, Inc. on April 26, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Averitas Pharma, Inc. (15 trademarks)

Morristown, NJ 07960

Entity Type: 03

Trademark Details

Filing Date

April 26, 2022

Registration Date

Not Registered

Published for Opposition

March 28, 2023

Goods & Services

Conducting of training courses in the field of medicine and pharmaceuticals; issuance and publication of books, journals and other communication media in print and electronic form, namely, publishing and issuing of books, journals and scientific papers in the field of medicine and pharmaceuticals, especially for pharmaceutical companies, pharmacists, physicians, patients, health insurance companies and their professional associations

Pharmaceutical preparations for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of inflammation and gout; vaccines; sanitary preparations for medical purposes; dietetic substances to support nutritional balance and to treat deficiencies, namely, vitamins, mineral supplements, and probiotic preparations adapted for medical use; Wound dressings; surgical dressings; bandages, medical adhesive patches and medical adhesive tapes for dressings; medical adhesives to bind wounds; bandages, medical adhesive patches, medical adhesive tapes and medical adhesives to close skin wounds, incisions and cuts

Scientific and technological services and research in the medical and pharmaceutical field, namely, pharmaceutical product development, product development of medical devices, development of healthcare software, development of healthcare informatics services and scientific study and research services in the fields of medicine and the prevention, treatment and management of illnesses, diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 23, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 23, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 5, 2024 EXRA
SOU EXTENSION 3 GRANTED
Dec 5, 2024 EX3G
SOU EXTENSION 3 FILED
Nov 20, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 20, 2024 EEXT
CORRECTED NOA E-MAILED
Aug 13, 2024 NOAC
DIVISIONAL PROCESSING COMPLETE
Aug 13, 2024 DPCC
RESPONSE TO ITU OFFICE ACTION ENTERED
Aug 7, 2024 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 7, 2024 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Aug 7, 2024 INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Jun 11, 2024 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 10, 2024 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2024 EXRA
DIVISIONAL REQUEST RECEIVED
May 2, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
May 2, 2024 ERTD
SOU EXTENSION 2 GRANTED
May 2, 2024 EX2G
SOU EXTENSION 2 FILED
May 2, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 2, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 22, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 20, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 20, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 20, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 23, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 28, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2023 CNEA
ASSIGNED TO EXAMINER
Feb 14, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2022 NWOS
NEW APPLICATION ENTERED
Apr 29, 2022 NWAP